Physician profile
Clive K Fields
NPI 1366447583
$2,335.53
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $720 · 2020: $701 · 2021: $564 · 2022: $293 · 2023: $57.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $57.34.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $57.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $247.76 | 2019-2022 | |
| Novo Nordisk INC | $240.94 | 2019-2022 | |
| Amarin Pharma, INC. | $226.16 | 2020-2022 | |
| Astellas Pharma US INC | $223.89 | 2019-2021 | |
| Abbott Laboratories | $206.35 | 2019-2023 | Proclaim |
| Janssen Pharmaceuticals, INC | $177.60 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $163.46 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $118.53 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $117.60 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.71 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $100.65 | 2019-2020 | |
| Esperion Therapeutics, INC. | $76.82 | 2020-2021 | |
| Allergan, INC. | $52.28 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $42.24 | 2019-2020 | |
| Axonics, INC. | $39.67 | 2023 | Axonics |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $39.17 | 2019-2020 | |
| Biosense Webster, INC. | $31.33 | 2021 | |
| Pfizer INC. | $28.88 | 2019 | |
| Glaxosmithkline, LLC. | $28.28 | 2019-2020 | |
| Tersera Therapeutics LLC | $17.98 | 2019 | |
| Neos Therapeutics, Lp | $17.50 | 2019 | |
| Amgen INC. | $13.46 | 2020 | |
| Currax Pharmaceuticals LLC | $11.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clive Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.